Randy In the wake of the COVID-19 pandemic, there has been a significant surge in public awareness regarding nutrition, health, and overall well-being. This newfound consciousness has driven a remarkable increase in the consumption of nutritional supplements worldwide. According to Grand View Research, the global dietary supplements market reached a staggering $164 billion in 2022, with a projected annual growth rate of 9% until 2030.
Amidst this flourishing and competitive landscape, a young entrepreneur from the Basque Country, Eduardo Arríen, has made a bold entrance. At just 28 years old, Arríen has co-founded the Spanish start-up Kobho Labs, along with investor Ignacio Arrieta and esteemed medical professionals Dr. Vicente Mera, Dr. Álvaro Campillo, and Elisa Blázquez. Their collective expertise spans internal medicine, anti-aging treatments, surgery, and clinical nutrition, respectively.
“Competition is fierce, with over 150 companies vying for each product,” remarks Arríen. Kobho’s strategy revolves around differentiation by democratizing access to high-quality products, customizing consumption, and ensuring maximum bioavailability—the proportion and speed at which nutrients are absorbed by the intestine.
The aging population and deteriorating dietary habits have contributed to the market’s exponential growth, and Kobho has swiftly carved out a niche for itself. Despite the project’s inception in 2021, the company began sales in January and has already established a presence in France, Italy, Germany, and Portugal.
To fuel its growth, Kobho has undergone three capital increases totaling €700,000 to date. With projected revenues surpassing €600,000 in 2023, Arríen anticipates further expansion through an upcoming capital increase exceeding €1 million in January. He attributes this success to the company’s commitment to value, emphasizing customer satisfaction and retention.
Arríen, a graduate in Business Administration from the University of Navarra, draws inspiration from his personal interests, including long-distance triathlons and nutritional supplementation. Kobho offers ten scientifically-backed products targeting digestive, cardiovascular, and cognitive health, anti-aging, longevity, and beauty. Future endeavors include supplements tailored for menopause and immune health.
“In the market, there was a gap for high-quality products at an affordable price,” asserts Arríen. He underscores the importance of establishing nutritional supplements as a sustainable health habit rather than a short-term solution, a philosophy reflected in Kobho’s pricing strategy. While competitors sell similar products at double the price, Kobho maintains a modest average price of €23 per item.
Arríen acknowledges that Kobho’s affordability comes at a cost. “We’re willing to forgo higher profits to democratize essential goods,” he states. The ultimate goal is to become synonymous with reliability and quality—a German car of the supplements industry—accessible to all without sacrificing excellence.
Kobho’s innovative approach extends beyond product pricing. The company, comprising a team of ten individuals, combines supplement sales through its website and pharmacies with a personalized program tailored to each consumer’s needs. By leveraging nutritional tests analyzing 314 genetic variants, 159 genes, and 35 different parameters, Kobho aims to align dietary recommendations and supplements with each individual’s genetic predispositions, effectively addressing deficiencies and potential health risks.
In collaboration with the ADN Institute, Kobho’s genetic testing program serves as a vital tool for detecting intolerances, vitamin deficiencies, and other health conditions influenced by genetic factors. This data informs the development of supplements designed to address specific needs, further solidifying Kobho’s commitment to personalized health solutions.
As Kobho Labs continues to disrupt the nutritional supplements market, its emphasis on accessibility, quality, and personalization sets a new standard for the industry. With Eduardo Arríen at the helm, the company is poised to not only meet but exceed the evolving demands of consumers worldwide, forging a path towards a healthier and more informed future.
Kobho Labs: Revolutionizing the Nutritional Supplements Market
In the wake of the COVID-19 pandemic, public awareness regarding nutrition, health, and overall well-being has surged, leading to a remarkable increase in the consumption of nutritional supplements worldwide. Grand View Research reports that the global dietary supplements market reached an impressive $164 billion in 2022, with projections indicating a 9% annual growth rate until 2030.
Amidst this flourishing and competitive landscape, a young entrepreneur from the Basque Country, Eduardo Arríen, has made a bold entrance. At just 28 years old, Arríen has co-founded the Spanish start-up Kobho Labs, along with investor Ignacio Arrieta and esteemed medical professionals Dr. Vicente Mera, Dr. Álvaro Campillo, and Elisa Blázquez. Their collective expertise spans internal medicine, anti-aging treatments, surgery, and clinical nutrition, respectively.
“Competition is fierce, with over 150 companies vying for each product,” remarks Arríen. Kobho’s strategy revolves around differentiation by democratizing access to high-quality products, customizing consumption, and ensuring maximum bioavailability—the proportion and speed at which nutrients are absorbed by the intestine.
The aging population and deteriorating dietary habits have contributed to the market’s exponential growth, and Kobho has swiftly carved out a niche for itself. Despite the project’s inception in 2021, the company began sales in January and has already established a presence in France, Italy, Germany, and Portugal.
To fuel its growth, Kobho has undergone three capital increases totaling €700,000 to date. With projected revenues surpassing €600,000 in 2023, Arríen anticipates further expansion through an upcoming capital increase exceeding €1 million in January. He attributes this success to the company’s commitment to value, emphasizing customer satisfaction and retention.
Arríen, a graduate in Business Administration from the University of Navarra, draws inspiration from his personal interests, including long-distance triathlons and nutritional supplementation. Kobho offers ten scientifically-backed products targeting digestive, cardiovascular, and cognitive health, anti-aging, longevity, and beauty. Future endeavors include supplements tailored for menopause and immune health.
“In the market, there was a gap for high-quality products at an affordable price,” asserts Arríen. He underscores the importance of establishing nutritional supplements as a sustainable health habit rather than a short-term solution, a philosophy reflected in Kobho’s pricing strategy. While competitors sell similar products at double the price, Kobho maintains a modest average price of €23 per item.
Arríen acknowledges that Kobho’s affordability comes at a cost. “We’re willing to forgo higher profits to democratize essential goods,” he states. The ultimate goal is to become synonymous with reliability and quality—a German car of the supplements industry—accessible to all without sacrificing excellence.
Kobho’s innovative approach extends beyond product pricing. The company, comprising a team of ten individuals, combines supplement sales through its website and pharmacies with a personalized program tailored to each consumer’s needs. By leveraging nutritional tests analyzing 314 genetic variants, 159 genes, and 35 different parameters, Kobho aims to align dietary recommendations and supplements with each individual’s genetic predispositions, effectively addressing deficiencies and potential health risks.
In collaboration with the ADN Institute, Kobho’s genetic testing program serves as a vital tool for detecting intolerances, vitamin deficiencies, and other health conditions influenced by genetic factors. This data informs the development of supplements designed to address specific needs, further solidifying Kobho’s commitment to personalized health solutions.
As Kobho Labs continues to disrupt the nutritional supplements market, its emphasis on accessibility, quality, and personalization sets a new standard for the industry. With Eduardo Arríen at the helm, the company is poised to not only meet but exceed the evolving demands of consumers worldwide, forging a path towards a healthier and more informed future.
